Philippine COVID-19 Living Clinical Practice Guidelines

Institute of Clinical Epidemiology, National Institutes of Health, UP Manila

In cooperation with the Philippine Society for Microbiology and Infectious Diseases
Funded by the DOH AHEAD Program through the PCHRD

DISCLAIMER

As a living guideline, the recommendations will be updated, and new recommendations will be added as the evidence evolves. The living recommendations are based on the best evidence available in scientific literature at the time of its formulation. However, this living CPG is not a comprehensive guide to all practice questions and management options on COVID-19. This is not meant to restrict the practitioner in using sound clinical judgement and sharing the decision with the patient, and from considering other management options according to the patient’s particular needs and preferences. This CPG can serve to inform policy, but it is not meant to serve as a basis for approving or denying financial coverage or insurance claims merely because of nonconformance with recommendations. Neither are the recommendations supposed to be considered as legal rules for dictating certain modes of action to the exclusion of others.